Global Menopausal Hot Flashes Market Analysis, Trends and Forecast by 2015 – 2023

The global menopausal hot flashes market had an opportunity worth US$3.77 bn in 2014. The market is projected to rise at a moderate CAGR of 3.7% over the period between 2015 and 2023, and rise to US$5.28 bn by 2023. Despite declining popularity, treatment methods based on estrogen and progestin remain the leading treatment methods in the market owing to the absence of effective alternatives. Hormone-based treatments will also continue to play a prominent role in the overall development of the market for many years to come.

In the moderately fragmented global market for menopausal hot flashes, the top eight companies accounted for a collective share of more than 50% in 2014, states TMR in a recent report. The top two vendors, Pfizer, Inc. and Novartis AG held a dominant share of nearly 30% of this, commanding a strong hold on the overall development prospects of the market.

Obtain Report Details @
http://www.transparencymarketresearch.com/menopausal-hot-flashes.html

Pfizer, the topmost vendor in the market, benefits from its strong foothold in North America, which happens to be the leading consumer of menopausal hot flashes treatment products across the globe. In the next few years, increased awareness regarding the potential effects of hormone-based treatments in triggering cancers and cardiovascular diseases in women will bring about major transformation in the overall dynamics of the global market.

Several leading therapies, such as Merck’s Colpotrophine (promestriene) and Pfizer’s Premarin, have lost patents and many products are also losing exclusivity. This will have a significant effect on the overall market dynamics in the next few years and witness the influx of cheaper generic treatment methods. Also, to support the rising demand for alternative treatment methods, companies in the market will increasingly invest on research and development of non-hormonal treatments for menopausal hot flashes.

Rising Prevalence of Menopausal Vasomotor Symptoms Remains Key Vehicle for Market’s Growth

The rising prevalence of menopausal vasomotor symptoms, especially across developed regions such as North America and Europe, is expected to be the most prominent stimulator for the global menopausal hot flashes market in the next few years. According to the North American Menopause Society, as many as 75% perimenopausal women in the U.S. experience hot flashes. Incidence rate of hot flashes in other western countries is also similar to the U.S., making these regions the prime destination for the menopausal hot flashes market.

Hormone-based therapies are presently the leading treatment modalities in the market. However, through 2023, concerns about the severe side-effects of hormone replacement therapies and their potential in triggering cardiovascular diseases and cancers will massively transform the menopausal hot flashes treatment paradigm. In effect, the market for once popular treatment modalities, including hormone pills, patches, and gels, will be taken over by alternative non-hormonal treatments. The dearth of effective alternatives capable of favoring this trend will be reflected in the moderate growth prospects of the global menopausal hot flashes market over 2015 to 2023.

Growing Awareness about Women’s Health in Developing Countries Presents Newfound Growth Opportunities

Several population-based surveys have demonstrated that there has been a swooping rise in health awareness among women across developed and developing parts of the world in the past few years. This factor has aided the increased adoption of a variety of treatment methods for menopause-related symptoms, especially in developing regions such as Asia Pacific.

Active efforts for raising healthcare awareness among women across developing and underdeveloped parts of the world could aid the increased adoption of treatments for a variety of menopause-related symptoms in the next few years. These regions present ample growth opportunities for the market owing to large population base and the rising number of women aged between 35 and 65 years.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2856

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Advertisements

Tagged:

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: